鱼跃医疗

002223.SZ

Wind Industry: 医疗保健 > 医疗设备与服务 > 医疗保健设备与用品 > 医疗保健设备

公司专注医疗器械的研发、生产、销售和服务，是国内领先的综合性医疗器械和解决方案供应商，致力于为全球患者和医疗机构提供高质量、创新性的医疗产品和服务。公司始终秉持“帮患者减轻痛苦，助医生提升医术”的使命，以消费者为核心专注生命健康事业，产品重点聚焦呼吸治疗、血糖管理及POCT、家用健康检测解决方案，扎根临床器械及康复解决方案，并积极孵化急救、眼科等高潜力解决方案。着眼于广阔的国际市场空间，公司以“创新重塑医疗器械”为战略方向，以强大的研发实力和技术创新能力为支撑，不断引领产业变革，为更多生命的蓬勃律动持续助力。历经多年发展，公司始终保持新产品、新项目的高研发投入和领先的科研创新能力，在德国、上海、南京、苏州、丹阳、西藏、深圳等地建立了多个研发中心和制造中心，拥有国家企业技术中心、国家工业设计中心、国家博士后科研工作站等多个科研创新平台，形成了完整的全球研发、生产、营销、服务网络，产品赢得了广泛的认可。公司还积极与国内外医疗机构开展合作，共同推动医疗行业的发展和进步，通过多元化的业务布局和持续的国际化拓展，更好地服务于全球医疗卫生事业。

ESG Score Industry Ranking:
2 / 151 (医疗保健设备与用品)

ESG Rating Distribution(医疗保健设备与用品)

0.66%

AAA

3.31%

15.23%

21.19%

BBB

49.67%

7.95%

CCC

Trend of Rating

About Wind ESG Rating

Wind has developed a rigorous rating methodology based on the core connotations of ESG, aligning with international standards and frameworks, and incorporating the characteristics of Chinese companies, to assess the company's essential ESG performance, risk and its ability to operate sustainably.

Focusing on the ESG risks and opportunities of each industry, the companies are rated on a AAA-CCC scale relative to the performance of their industry peers. Wind ESG rating is updated annually or in response to major changes.

The Wind ESG Rating Issuer Communication Platform (esg.wind.com.cn) is now available. Rated companies can access their detailed rating information through this platform, and communicate with or provide feedback to the Wind ESG Rating team regarding specific rating components. For any additional questions, please feel free to send an email to GR.ESG@wind.com.cn.

ESG Score

ESG Score：8.44Updated on 2026-10-29

08.4410

Management & Practices Score：5.47Updated on 2026-10-28

05.477

Controversies Score：2.97Updated on 2026-10-29

02.973

ESG Score Comparison

Indicator	Company Score	Industry Average	Weight
Environmental	7.99	2.78	5.84%
Social	7.85	3.82	65.37%
Governance	7.72	5.86	28.77%

Wind ESG Rating Framework

Building on the foundation of domestic and international ESG policies and standards, our proprietary ESG rating framework considers the development of Chinese capital market and integrates the characteristics of the Chinese companies in various industries. The Wind ESG Rating framework is composed of management & practice and controversies assessment, including:

500+ management & practices indicators, covering E, S and G pillars, reflecting long-term ESG fundamental impacts
1,200+ risk labels, covering news, regulatory penalties and lawsuits, reflecting impact of short-term risks

Management & practice score is the weighted summation of E, S and G pillar scores. The weights reflect both the relative impact of each issue within each industry and the negative or positive contribution of each industry to the environment and society relative to other industries.

Controversies score and ESG score are updated daily, E, S and G pillar scores and management & practice score are updated with underlying data, corresponding data are released on various channels, including Wind Financial Terminal.

Explore More

Wind ESG Rating Methodology.pdf1,198KB Wind ESG Ratings FAQs.pdf755KB

More Details

Peer Comparison(151 companies in the industry) ?

Ranking	Code	Security Name	ESG Rating	ESG Score	Controversies Score	Management & Practices Score	Environmental	Social	Governance
1	688139.SH	海尔生物	AAA	8.91	2.98	5.93	8.20	8.84	7.69
2	002223.SZ	鱼跃医疗	AA	8.44	2.97	5.47	7.99	7.85	7.72
3	300760.SZ	迈瑞医疗	AA	8.41	2.99	5.42	6.67	7.34	8.87
4	300888.SZ	稳健医疗	AA	8.37	3.00	5.38	7.76	7.52	8.03
5	688029.SH	南微医学	AA	8.09	2.99	5.10	6.96	7.48	6.88
6	300298.SZ	三诺生物	AA	7.90	2.98	4.93	5.48	6.97	7.51
7	605369.SH	拱东医疗	A	7.85	2.97	4.88	4.37	7.00	7.42
8	300981.SZ	中红医疗	A	7.77	2.97	4.80	2.82	6.96	7.44
9	300832.SZ	新产业	A	7.75	2.88	4.87	4.67	6.99	7.35
10	0853.HK	微创医疗	A	7.72	2.90	4.82	6.88	7.64	5.17